Project Grant R01CA286120
Award Date
9/18/24
Completion Date
8/31/29
Dollars Obligated
$645K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This federal Project Grant award of $572,490.00 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports the development of PILLAR, an AI-based tool to predict breast cancer risk from longitudinal multi-modal breast imaging data. The project aims to create novel machine learning architectures and self-supervised learning algorithms to improve the accuracy of cancer risk assessment compared to current models. Additionally, the team will develop methods...
This $989,122 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to evaluate the performance of commercial mammography-based artificial intelligence (AI) algorithms for breast cancer risk prediction in diverse U.S. screening populations. The project will assess the accuracy and utility of four commercial mammography-based AI breast cancer risk models compared to currently used clinical risk factor-based...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), aims to develop enhanced cancer risk prediction models for underrepresented populations, particularly Black and Hispanic individuals. The $432,304 grant, awarded on January 3, 2025, will fund the development of novel data integration and machine learning methods to effectively leverage multi-source electronic health record (EHR) and biobank data. The...
This federal Project Grant award of $684,333 from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to evaluate whether patient and provider decision support that compares breast cancer and cardiovascular disease risk can improve the acceptance and uptake of chemoprevention among racially/ethnically diverse women at high risk for breast cancer. The key products and services to be delivered under this 5-year grant, which begins on...
This $2,035,551 federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports the development and external validation of new personalized colorectal cancer (CRC) risk prediction models tailored for Black American men and women. The award recipient, Trustees of Boston University, will leverage longitudinal data from large prospective cohorts of Black adults to build dynamic risk models using advanced...
This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Project Grant award (CFDA 47.070) of $195,000 will fund the development of a weakly-supervised breast cancer detection system using active and weakly-supervised learning techniques to improve breast cancer diagnosis from ultrasound images. The project aims to create a deep learning model that can detect breast cancer effectively with minimal annotations, addressing the challenges of noisy, low-contrast...
The National Institutes of Health (NIH) Office of the Director awarded a $670,634 Project Grant (CFDA 93.310 Trans-NIH Research Support) to the University of Connecticut (UConn) to optimize and personalize breast cancer screening through advanced artificial intelligence (AI) algorithms. The overarching objective is to develop a robust, multimodal, and longitudinal AI-based computer-aided detection (AI-CAD) system that can improve breast cancer detection and localization by integrating digital...
This Project Grant award from the National Science Foundation Division of Information and Intelligent Systems provides $350,000 in funding to the University of Illinois from September 2022 through August 2026. The award supports research under the Computer and Information Science and Engineering federal grant program (CFDA 47.070). Specifically, the University of Illinois will develop a machine learning framework for training models across hospitals to support precision population health and...
The National Cancer Institute (NCI) awarded a $450,000 Project Grant under the Cancer Biology Research (CFDA 93.396) program to The Research Foundation for the State University of New York, doing business as Stony Brook University. The purpose of this 4-year grant is to develop advanced topological data analysis (TDA) methods, called "TopQuant," to extract and interpret fine-grained structural information from breast imaging data. The goal is to better understand breast tissue...
This $673,366 project grant awarded by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop a novel X-ray dual-energy cone-beam microCT (DECB microCT) system for intraoperative imaging of lumpectomy specimens during breast-conserving surgery (BCS). The key objectives are to: (1) develop the DECB microCT technology to enable enhanced contrast differentiation between breast cancer and normal fibroglandular tissue, (2)...